Thomas Struengmann

Holzkirchen, Germany

Thomas Struengmann

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 31(Granted Patents)

Forward Citations (Not Self Cited) = 28(Sep 21, 2024)


Years Active: 1998

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Thomas Struengmann: Innovator in Transdermal Drug Delivery

Introduction: Thomas Struengmann, based in Holzkirchen, Germany, is a noteworthy inventor recognized for his contributions to the field of pharmaceutical innovations. With a focus on enhancing drug delivery methods, he holds a patent that showcases his commitment to improving healthcare solutions.

Latest Patents: Struengmann's most significant achievement is his patent for a transdermal drug preparation, which aims to facilitate the effective delivery of medications through the skin. This innovative approach has the potential to enhance patient compliance and improve therapeutic outcomes.

Career Highlights: Struengmann has built a successful career at Haxal AG, where he continuously works on pioneering advancements in drug formulation and delivery. His expertise in pharmaceutical technology has made him an asset to the company and the broader biomedical community.

Collaborations: Throughout his career, Struengmann has collaborated closely with his coworker, Wilfried Fischer. Their partnership has led to meaningful developments in drug delivery systems, reinforcing the importance of teamwork in the innovation process.

Conclusion: Thomas Struengmann stands as a prominent figure in the world of pharmaceutical inventions. Through his patent for transdermal drug preparation and collaborative efforts at Haxal AG, he continues to make strides in improving healthcare technologies. His work is reflective of the vital role inventors play in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…